Back to Journals » Drug Design, Development and Therapy » Volume 11

Efficacy of the dual PI3K and mTOR inhibitor NVP-BEZ235 in combination with imatinib mesylate against chronic myelogenous leukemia cell lines

Total article views   HTML views PDF downloads Totals
10,046 Dovepress* 9,220+ 1,406 10,626
PubMed Central* 826 310 1,136
Totals 10,046 1,716 11,762
*Since 3 April 2017
Total mentioned Facebook Delicious Reddit Twitter Others
8 1 0 0 2 5

View citations on PubMed Central and Google Scholar